141
Participants
Start Date
April 22, 2021
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2027
Tovorafenib
Tovorafenib is an oral Type II RAF kinase inhibitor available in 100 mg immediate-release tablet or 25 mg/milliliter (mL) powder for reconstitution.
RECRUITING
The Children's Hospital at Westmead, Westmead
RECRUITING
Royal Children's Hospital, Parkville
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital - Yonsei University, Seoul
RECRUITING
Queensland Children's Hospital, Brisbane
RECRUITING
Universitäts-Kinderspital Zürich - Eleonorenstiftung, Zurich
RECRUITING
NYU Langone Health, New York
RECRUITING
Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Otto-Heubner-Centrum für Kinder, Berlin
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
RECRUITING
Children's National Medical Center, Washington D.C.
TERMINATED
Johns Hopkins Hospital, Baltimore
RECRUITING
Duke Cancer Center, Durham
RECRUITING
CS Mott Children's Hospital, Ann Arbor
RECRUITING
Lurie Children's Hospital of Chicago, Chicago
RECRUITING
St. Louis Children's Hospital, St Louis
RECRUITING
Hopp-Kindertumorzentrum Heidelberg (KiTZ), KiTZ Clinical Trial Unit (ZIPO), Heidelberg
RECRUITING
Texas Children's Hospital, Houston
RECRUITING
University of Utah, Salt Lake City
RECRUITING
UCSF Benioff Children's Hospital, San Francisco
TERMINATED
Doernbecher Children's Hospital Oregon & Health Science University, Portland
RECRUITING
Seattle Children's Hospital, Seattle
RECRUITING
KK Women's and Children's Hospital, Singapore
RECRUITING
Rambam Health Care Campus, Haifa
RECRUITING
Schneider Children's Medical Center of Israel, Petah Tikva
RECRUITING
The Chaim Sheba Medical Center, Ramat Gan
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Perth Children's Hospital, Perth
RECRUITING
Sydney Children's Hospital, Randwick
RECRUITING
Centre Hospitalier Universitaire Ste-Justine, Montreal
RECRUITING
Montreal Children's Hospital, Montreal
RECRUITING
Centre Mère-Enfant Soleil du CHU, Québec
RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Princess Maxima Center for Pediatric Oncology, Utrecht
RECRUITING
UCL Great Ormond Street Institute of Child Health, London
RECRUITING
Newcastle University, Newcastle upon Tyne
Lead Sponsor
Pacific Pediatric Neuro-Oncology Consortium
OTHER
Day One Biopharmaceuticals, Inc.
INDUSTRY